Search

Search Results

• DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

  alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini

  e2019044

  2019-06-25

  https://doi.org/10.4084/mjhid.2019.044

  2003

  PDF: 1537

  HTML: 452

• SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN

  Hanaa El-Karaksy, Mona El-Raziky

  e2011027

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.027

  2223

  PDF: 933

  HTML: 1659

• EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION

  Mehrez M. Jadaon

  e2011054

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.054

  2791

  PDF: 1145

  HTML: 2820

• EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

  Mehrez Mehrez M. Jadaon

  e2011037

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.037

  3172

  PDF: 825

  HTML: 12914

• CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA

  Valerio De Stefano, Tommaso Za, Angela Ciminello, Laura Betti, Elena Rossi

  e2011063

  2011-12-19

  https://doi.org/10.4084/mjhid.2011.063

  2651

  PDF: 953

  HTML: 3641

• FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY

  Oshrat E. Tayer-Shifman, Eldad Ben-Chetrit

  e2011017

  2011-05-15

  https://doi.org/10.4084/mjhid.2011.017

  1245

  PDF: 726

  HTML: 1249

• CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN

  S Menascu, A Lotan, B Ben Zeev, U Nowak- Gottl, G Kenet

  e2011029

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.029

  2541

  PDF: 970

  HTML: 2246

• MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS

  Lucio Amitrano, Maria Anna Guardascione

  e2009014

  https://doi.org/10.4084/mjhid.2009.014

  836

  PDF: 547

  HTML: 4026

• SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

  Zohreh Rahimi, Abbas Parsian

  e2011024

  2011-05-23

  https://doi.org/10.4084/mjhid.2011.024

  2306

  PDF: 921

  HTML: 2106

• SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

  Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

  e2024020

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.020

  1121

  PDF: 1258

  HTML: 114

• CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease

  Vincenzo De Sanctis

  e2020032

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.032

  2251

  PDF: 1448

  HTML: 793

• Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy

  Kun Yang

  e2024017

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.017

  628

  PDF: 1070

  HTML: 98

• Massive pulmonary embolism at the onset of acute promyelocytic leukemia

  Federica Sorà, Patrizia Chiusolo, Luca Laurenti

  e2016027

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.027

  3569

  PDF: 909

  HTML: 1670

  figure 1: 174

  Untitled: 201

• EARLY AND LATE COMPLICATIONS RELATED TO CENTRAL VENOUS CATHETERS IN HAEMATOLOGICAL MALIGNANCIES: A RETROSPECTIVE ANALYSIS OF 1102 PATIENTS

  Salvatore Giacomo Morano, Lorenzo Coppola, Roberto Latagliata, Paola Berneschi, Antonio Chistolini, Alessandra Micozzi, Corrado Girmenia, Massimo Breccia, Gregorio Brunetti, Angela Matturro, Giovanni Rosa, Pietro Guerrisi, Franco Mandelli, Roberto Foà, Giuliana Alimena

  e2014011

  2014-02-18

  https://doi.org/10.4084/mjhid.2014.011

  3077

  PDF: 976

  HTML: 1561

• CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS

  Nilüfer Yeşilot Barlas, Gülşen Akman-Demir, Sara Zarko Bahar

  e2011044

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.044

  2309

  PDF: 777

  HTML: 1283

• Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

  Bhavya S Doshi, Valder R Arruda, Valder R Arruda

  e2020069

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.069

  2156

  PDF: 1939

  HTML: 357

• REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIE?TS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS

  Vincenzo De Sanctis

  e2017001

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.001

  6182

  PDF: 1449

  HTML: 1943

• MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

  Davide Matino, Paul Tieu, Dr., Antony Chan

  e2020001

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.001

  3389

  PDF: 1631

  HTML: 456

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  2993

  PDF: 1047

  HTML: 4608

• NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY

  Francesco Rodeghiero, Dr. Mariasanta Napolitano, Nicola Vianelli, Lisanna Ghiotto, Silvia Cantoni, Giuseppe Carli, Monica Carpenedo, Valentina Carrai, Ugo Consoli, Gaetano Giuffrida, Elisa Lucchini, Elena Rossi, Cristina Santoro

  e2023019

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.019

  2287

  PDF: 1259

  PDF Appendix: 747

  HTML: 454

• CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

  Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda

  e2019067

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.067

  2975

  PDF: 1874

  HTML: 775

• Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

  Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso

  e2022058

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.058

  1717

  PDF: 799

  HTML: 267

• ON THE VERSATILITY OF VON WILLEBRAND FACTOR

  Antoine Rauch, Peter Lenting

  e2013046

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.046

  2872

  PDF: 1158

  HTML: 11229

• VIRAL CIRRHOSIS: AN OVERVIEW OF HAEMOSTATIC ALTERATIONS AND CLINICAL CONSEQUENCES

  Francesca Romana Ponziani, Valerio De Stefano, Antonio Gasbarrini

  e2009033

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.033

  2693

  PDF: 521

  HTML: 3472

• COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

  Federico Mercolini, Simone Cesaro

  e2022009

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.009

  2579

  PDF: 960

  HTML: 356

• Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.

  Maria Dmitrievna Sanatko

  e2012047

  2012-06-30

  https://doi.org/10.4084/mjhid.2012.047

  2466

  PDF: 885

  HTML: 692

  Untitled: 238

• THE PERFORMANCE OF 2023 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) / EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY (EULAR) ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA IN A REAL-WORLD RHEUMATOLOGY DEPARTMENT

  Ahmet Usta, Müçteba Enes Yayla, Emine Uslu, Serdar Sezer, Ebru Us, Aşkın Ateş, Murat Turgay

  e2024074

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.074

  1384

  PDF: 693

  Suppl. Files: 386

  HTML: 247

• COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

  Stefan Hohaus, Luciana Teofili, Mario Balducci, Stefania Manfrida, Angelo Pompucci, Francesco D'Alo', Giuseppina Massini, Luigi Maria Larocca, Roberto Marra, Sergio Storti

  e2009020

  2009-12-14

  https://doi.org/10.4084/mjhid.2009.020

  2266

  PDF: 540

  HTML: 2292

• Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia

  Jérôme Guison, Gilles Blaison, Oana Stoica, Remy Hurstel, Marie Favier, Remi Favier

  e2017038

  2017-06-16

  https://doi.org/10.4084/mjhid.2017.038

  2225

  PDF: 851

  HTML: 938

  Patient’s family tree: 185

• A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid

  Irina Panovska-Stavridis

  e2021048

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.048

  1346

  PDF: 496

  HTML: 407

• NEW STRATEGIES FOR STEM CELL MOBILIZATION

  Roberto Lemoli

  e2012066

  2012-10-03

  https://doi.org/10.4084/mjhid.2012.066

  2499

  PDF: 895

  HTML: 2472

• Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

  Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini

  e2024047

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.047

  1188

  PDF: 1011

  HTML: 95

• COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

  M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher

  e2009029

  2009-12-28

  1198

  PDF: 492

  HTML: 8190

• INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

  M. Al Huneini, Anil Pathare

  e2017028

  2017-04-20

  https://doi.org/10.4084/mjhid.2017.028

  2197

  PDF: 949

  HTML: 1375